4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000042
Options or other derivatives
- EVP, Chief Business Officer acquired 28,839 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-15 | Grant or award : show line 1 in the form Performance Restricted Stock Units | +12,290 | $0.00 | 12,290 | 12,290 | D |
| 2023-01-15 | Grant or award : show line 2 in the form Restricted Stock Unit | +14,749 | $0.00 | 14,749 | 58,099 | D |
| 2023-01-15 | Grant or award : show line 3 in the form Restricted Stock Unit | +1,800 | $0.00 | 1,800 | 4,866 | I |
Loading xslF345X03/edgardoc.xml…